¡Ya estamos en !
Descubre más
Dyne Therapeutics
14.25
USD
-1.04
6.8%
Al cierre
Actualizado
16 oct, 4:00 p.m. EDT
Antes de la apertura del mercado
Después del cierre del mercado
14.50
+0.25
1.75%
1 día
-6.8%
5 días
-13.85%
1 mes
-17.68%
3 meses
-37.28%
6 meses
-28.43%
En lo que va del año
-22.97%
1 año
-13.22%
5 años
0.49%
10 años
-40.38%
Nuevas
Aumentadas
Mantenido
Reducidas
Cerradas
AUM masivo
Más de $200 mil millones
AUM elevado
De $10 mil millones a $200 mil millones
AUM medio
De $2B a $10B
AUM bajo
De $250M a $2B
AUM micro
Menos de $250M
Menos de 10%
Menos de 20%
Menos de 40%
Menos de 60%
Menos de 80%
| # | Nombre | Posición | Valor operado |
Cambio en acciones |
Cambio en la participación |
|
|---|---|---|---|---|---|---|
| 1 |
1
T. Rowe Price Investment Management
Baltimore,
Maryland
| USD 687 M | +USD 2.35 M | +126,486 | +0.4% |
|
| 2 |
2
BlackRock
New York
| USD 276 M | +USD 13.1 M | +704,460 | +6% |
|
| 3 |
3
Jupiter Topco
New York
| USD 267 M | +USD 223 M | +11,997,738 | Nuevas |
|
| 4 |
4
Fidelity Investments
Boston,
Massachusetts
| USD 249 M | +USD 42.7 M | +2,298,020 | +26% |
|
| 5 |
5
State Street
Boston,
Massachusetts
| USD 166 M | +USD 15 M | +804,517 | +12% |
|
| 6 |
6
Orbis Allan Gray
Hamilton,
Bermuda
| USD 156 M | +USD 4.54 M | +244,311 | +4% |
|
| 7 |
7
Atlas Venture Life Science Advisors
Cambridge,
Massachusetts
| USD 151 M | -USD 43.3 M | -2,330,366 | -26% |
|
| 8 |
8
Vanguard Capital Management
Malvern,
Pennsylvania
| USD 140 M | -USD 1.75 M | -94,100 | -1% |
|
| 9 |
9
TCG Crossover Management
Palo Alto,
California
| USD 103 M | – | – | – |
|
| 10 |
10
Vanguard Portfolio Management
Malvern,
Pennsylvania
| USD 89.9 M | -USD 2.11 M | -113,613 | -3% |
|
| 11 |
11
T. Rowe Price Associates
Baltimore,
Maryland
| USD 87.4 M | +USD 29.9 M | +1,608,433 | +69% |
|
| 12 |
12
FCPM III Services
Naarden,
Netherlands
| USD 85.5 M | -USD 14.8 M | -796,130 | -17% |
|
| 13 |
13
Geode Capital Management
Boston,
Massachusetts
| USD 83.2 M | +USD 4.45 M | +239,313 | +7% |
|
| 14 |
14
Vestal Point Capital
New York
| USD 75 M | -USD 11.6 M | -625,000 | -16% |
|
| 15 |
15
OrbiMed
New York
| USD 71.9 M | +USD 5.91 M | +317,800 | +11% |
|
| 16 |
16
Frazier Life Sciences Management
Palo Alto,
California
| USD 70 M | – | – | – |
|
| 17 |
17
Armistice Capital
New York
| USD 68.6 M | -USD 1.63 M | -87,884 | -3% |
|
| 18 |
18
JP Morgan Chase
New York
| USD 67.2 M | -USD 1.89 M | -101,817 | -3% |
|
| 19 |
19
Perceptive Advisors
New York
| USD 59.7 M | -USD 36.8 M | -1,979,604 | -42% |
|
| 20 |
20
Logos Global Management
San Francisco,
California
| USD 56.6 M | +USD 21.4 M | +1,150,000 | +82% |
|
| 21 |
21
Bank of America
Charlotte,
North Carolina
| USD 49.6 M | +USD 14.7 M | +790,085 | +55% |
|
| 22 |
22
VR Adviser
New York
| USD 48.3 M | – | – | – |
|
| 23 |
23
Goldman Sachs
New York
| USD 47.9 M | +USD 8.07 M | +434,079 | +25% |
|
| 24 |
SL
24
Siren LLC
Greenwich,
Connecticut
| USD 47.3 M | -USD 1.86 M | -100,000 | -4% |
|
| 25 |
25
Franklin Resources
San Mateo,
California
| USD 45.1 M | +USD 404 k | +21,737 | +1% |
|